rdf:type |
|
lifeskim:mentions |
umls-concept:C0017968,
umls-concept:C0024109,
umls-concept:C0036525,
umls-concept:C0041385,
umls-concept:C0049517,
umls-concept:C0085535,
umls-concept:C0087111,
umls-concept:C0392747,
umls-concept:C0431085,
umls-concept:C0673362,
umls-concept:C1261473,
umls-concept:C1522484,
umls-concept:C1554963
|
pubmed:issue |
2
|
pubmed:dateCreated |
1988-5-6
|
pubmed:abstractText |
Synthesis and expression of cell surface carbohydrates appear to be involved in recognition events associated with tumor invasion and metastasis. Thus, the potential of murine sarcoma L-1 cells to form experimental lung metastases after i.v. injection was assessed after inhibiting tumor cell protein glycosylation with tunicamycin, swainsonine, bromoconduritol, or 1-desoxynojirimycin. Incubation of sarcoma L-1 cells with 0.5 microgram (or above) of these substances/ml medium for 20-24 h significantly inhibited lung colonization. Cytotoxic side effects or additional organ manifestations could not be found. Gas liquid chromatographic examinations of carbohydrates from treated L-1 cells indicated that sugar synthesis was evidently inhibited. These results suggest that specific glycan structures on tumor cells are required for expression of the metastatic phenotype.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0171-5216
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
217-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2965156-1-Deoxynojirimycin,
pubmed-meshheading:2965156-Alkaloids,
pubmed-meshheading:2965156-Animals,
pubmed-meshheading:2965156-Carbohydrates,
pubmed-meshheading:2965156-Cyclohexenes,
pubmed-meshheading:2965156-Glucosamine,
pubmed-meshheading:2965156-Glycoproteins,
pubmed-meshheading:2965156-Inositol,
pubmed-meshheading:2965156-Lung Neoplasms,
pubmed-meshheading:2965156-Male,
pubmed-meshheading:2965156-Mice,
pubmed-meshheading:2965156-Mice, Inbred BALB C,
pubmed-meshheading:2965156-Sarcoma, Experimental,
pubmed-meshheading:2965156-Swainsonine,
pubmed-meshheading:2965156-Tunicamycin
|
pubmed:year |
1988
|
pubmed:articleTitle |
Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice.
|
pubmed:affiliation |
Institute of Hygiene, University of Cologne, Federal Republic of Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|